← All Cg Oncology, INC filings

Cg Oncology, INC Form 4 insider transactions

NASDAQ
CGON
Cg Oncology, INC
Form 4: CG Oncology Executive Acquires Stock Options
Joshua F. Patterson, General Counsel and Chief Compliance Officer of CG Oncology, Inc., acquired stock options on October 4, 2024.
NASDAQ
CGON
Cg Oncology, INC
Form 4: CG Oncology CEO Arthur Kuan Acquires Stock Options
Arthur Kuan, CEO of CG Oncology, acquired stock options for 397,800 shares at an exercise price of $36.63 on October 4, 2024.
NASDAQ
CGON
Cg Oncology, INC
Form 4: CG Oncology Director Hong Fang Song Sells Shares in Recent Transaction
Director Hong Fang Song reports the sale of CG Oncology (CGON) shares held indirectly through investment entities.
NASDAQ
CGON
Cg Oncology, INC
Form 4: CG Oncology Executive Acquires 100,000 Stock Options
Joshua F. Patterson, General Counsel and Chief Compliance Officer of CG Oncology, Inc., acquired 100,000 stock options on May 15, 2024.
NASDAQ
CGON
Cg Oncology, INC
4/A: Decheng Capital Corrects Form 4 Filing, Discloses Omitted CG Oncology Stock Purchase
Decheng Capital amends its previous SEC filing to include a purchase of 400,000 shares of CG Oncology common stock at $19 per share on January 29, 2024.